$230.0 Million
Natera, Inc.
Follow-On Offering
Active Bookrunner
$460.0 Million
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$322.6 Million
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
$69.0 Million
ASLAN Pharmaceuticals Pte. Ltd.
Follow-On Offering
Active Bookrunner
$125.0 Million
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
$115.0 Million
Revance Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$200.0 Million
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
$197.8 Million
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$111.3 Million
OptiNose AS
Follow-On Offering
Active Bookrunner
$260.3 Million
Xencor, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.